AUROBINDO PHARMA LTD Peer Comparison
AUROPHARMA · Healthcare · Current price ₹1,666.9
Peers tracked
11
AUROBINDO PHARMA LTD P/E
27.6x
Sector
Healthcare
AUROBINDO PHARMA LTD vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,758.8 | 36.9x | 4,21,995 |
| DIVI S LABORATORIES LTD | ₹9,144.5 | 85.4x | 2,42,758 |
| TORRENT PHARMACEUTICALS L | ₹4,558.9 | 86.9x | 1,73,406 |
| ZYDUS LIFESCIENCES LTD | ₹1,123 | 24.3x | 1,12,020 |
| LAURUS LABS LIMITED | ₹2,060.1 | 95.9x | 1,11,310 |
| CIPLA LTD | ₹1,325.1 | 33.2x | 1,07,051 |
| DR. REDDY S LABORATORIES | ₹1,233 | 29.9x | 1,02,916 |
| AUROBINDO PHARMA LTD | ₹1,666.9 | 25.9x | 95,910 |
| MANKIND PHARMA LIMITED | ₹2,275.5 | 44.9x | 93,988 |
| LUPIN LIMITED | ₹1,961.6 | 17.1x | 89,702 |
| GLENMARK PHARMACEUTICALS | ₹2,226.7 | 37.9x | 62,843 |
AUROBINDO PHARMA LTD versus its peers
AUROBINDO PHARMA LTD operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 27.6x may be cheap in one industry and expensive in another.
More on AUROBINDO PHARMA LTD
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.